BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16172112)

  • 1. Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis.
    Viganó P; Somigliana E; Chiodo I; Abbiati A; Vercellini P
    Hum Reprod Update; 2006; 12(1):77-89. PubMed ID: 16172112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic changes between endometriosis and ovarian cancer.
    Obata K; Hoshiai H
    Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.
    Dinulescu DM; Ince TA; Quade BJ; Shafer SA; Crowley D; Jacks T
    Nat Med; 2005 Jan; 11(1):63-70. PubMed ID: 15619626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic defects in endometriosis.
    Thomas EJ; Campbell IG
    Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
    Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
    Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
    Jiang X; Morland SJ; Hitchcock A; Thomas EJ; Campbell IG
    Cancer Res; 1998 Apr; 58(8):1707-12. PubMed ID: 9563487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
    Munksgaard PS; Blaakaer J
    Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
    Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
    Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
    Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
    Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
    Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The malignant potential of ovarian atypical endometriosis].
    Guo L; Liu T; Lang J
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
    Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
    Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An approach to early genetic alterations in precancerous cells].
    Sato N; Nishida M; Noguchi M
    Hum Cell; 2000 Sep; 13(3):103-8. PubMed ID: 11197771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heritability and molecular genetic studies of endometriosis.
    Bischoff FZ; Simpson JL
    Hum Reprod Update; 2000; 6(1):37-44. PubMed ID: 10711828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endometriosis in cancer and tumor development.
    Swiersz LM
    Ann N Y Acad Sci; 2002 Mar; 955():281-92; discussion 293-5, 396-406. PubMed ID: 11949955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometriosis: candidate genes.
    Campbell IG; Thomas EJ
    Hum Reprod Update; 2001; 7(1):15-20. PubMed ID: 11212068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.